|
|
|
|
|
|
|
|
|
![]() Patient with early ALS demonstrating selective wasting of the right hand favoring thenar over hypothenar muscles. Note the incomplete fisting (right upper panel) and the resulting inability to button with that hand (right lower panel) due to loss of the pincer or precision grip. |
|
|
|
|
|
|
-
Weakness of knee flexion (hamstring), foot eversion (superficial peroneal), foot inversion (tibialis anterior), foot dorsiflexion (tibialis anterior), and foot plantar flexion (gastrocnemius and soleus).
-
Preservation of iliopsoas, hip adductors, and quadriceps muscles
-
Absent ankle reflex with normal patellar reflex
-
Acute motor axonal neuropathy (AMAN) or “Chinese paralytic syndrome,” most common form of GBS in Asia
-
Acute motor and sensory axonal neuropathy (AMSAN): more rapid onset and severe weakness; recovery is slower and incomplete
-
Pharyngeal-cervical-brachial (PCB) weakness
-
MMN: Multifocal motor neuropathy with motor conduction block and anti-GM1 and anti-GD1a antibodies presents with asymmetric distal upper extremity and differential finger extension weakness, reflecting vulnerability of terminal branches of the posterior interosseous nerve. Unlike classic CIDP, CSF protein is normal.
-
DADS: Distal acquired demyelinating symmetric neuropathy is a symmetric predominantly sensory polyneuropathy whereby patients often have IgM monoclonal gammopathies with anti-MAG (myelin-associated glycoprotein) antibodies. Presence of these IgM M-proteins is associated with steroid failure.
-
IgG4-related nodopathy/paranodopathy is due to IgG4 antibodies to nodal and paranodal proteins, such as contactin-1 (CNTN1), neurofascin 155 (NF155), and contactin-associated protein 1 (Caspr1). This subacute CIDP/GBS variant presents with early and severe axonal invol vement and sensory ataxia and responds better to corticosteroids and rituximab than IVIg.
|
-
Cervical spondylotic myelopathy
-
Multifocal motor neuropathy with or without anti-GM1 antibodies
-
Inclusion body myositis
-
Others: spinocerebellar ataxia type 2 (SCA2), ATP13A2 mutations (juvenile-onset ALS besides Kufor-Rakeb syndrome, spastic paraplegia 78, and neuronal ceroid lipofuscinosis type 12 [CLN12]), toxins (lead, organophosphates), drugs (dapsone used for dermatitis herpetiform and malabsorption enteropathy [onset in hands, asymmetric]), infections (syphilis, borreliosis, CJD), metabolic disorders (porphyria, hyperparathyroidism, diabetes), hexosaminidase A deficiency (adult GM2 gangliosidosis or Tay-Sachs disease), and polyglucosan body disease (GSD IV)
-
Hereditary spastic paraparesis (HSP) may have AD (up to 70% of “pure” cases), AR, and X-linked modes of inheritance. AD form expresses at an older age (after 35 years) and is slower in progression (see next section).
-
Lathyrism refers to the selective UMN glutamatergic toxicity caused from the neurotoxin of Lathyrus sativus, chickpea, widely consumed in famine-stricken countries where this drought-resistant crop can be cultivated.
-
X-linked bulbospinal neuronopathy (Kennedy disease) affects only males with predominantly bulbar weakness (prominent tongue and chin fasciculations) but lesser progression to dysphagia and dysarthria. Gynecomastia occurs in up to 90% of cases. Other endocrinopathies are testicular atrophy and diabetes mellitus. Sensory involvement may occur. There exists CAG repeat expansion in the androgen receptor gene.
-
Multifocal motor neuropathy (MMN) presents in older males as asymmetric focal weakness of distal limbs, with relative preservation of muscle bulk. It results from peripheral motor fiber demyelination instead of motoneuronal cell bodies. EMG shows conduction block in various nerves. High titers of anti-GM1 ganglioside antibodies are present. Half the patients respond to periodic high-dose IVIG but not to prednisone.
-
Monomelic amyotrophy (MMA) aka Hirayama disease is a male-predominant, slow-progressing, self-limited “benign focal SMA,” often restricted to adjacent myotomes of one arm with limb wasting but relatively well-preserved strength. This disorder is apparently sporadic and more common in Japan and India.
-
Adult-onset spinal muscular atrophy (SMA type IV) is distinguished by a family history (70% AR as in the childhood-onset SMAs and 30% AD; deletions in the 5q chromosome are rare) and a slowly progressive and symmetric limb-girdle weakness of the legs. Survival is over 20 years. The antisense oligonucleotide nusinersen (Spinraza) has been approved for children and adults with SMA.
-
Postpolio muscular atrophy is a focal and asymmetric muscle weakness that progresses from same regions previously affected by polio which had been stable for at least 10 years.
|
|
![]() * HSPs with lower-motor neuron disease (ALS-like phenotype) include SPG4, SPG9A, SPG11, SPG14, SPG15, SPG17, SPG20, SPG21, SPG26, SPG38, SPG39, SPG43, SPG62, and SPG64.
IFIH1 gene (2q24.2) leads to an HSP associated with multisystemic inflammation, including interstitial lung disease, oral ulceration, diffuse hair loss, dermatomyositis, Raynaud phenomenon, and arthritis. |
|
|

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

